City Therapeutics Raises $99.5M in Series B Funding

June 9, 2026

City Therapeutics, Inc., a Cambridge, MA-based biopharmaceutical company developing RNA interference (RNAi)-based medicines, raised $99.5M in Series B funding

Search

RECENT PRESS RELEASES

The impact of sports on building community ties in World Cup 2026 Prediction Today

SWI Editorial Staff2026-06-09T01:47:01-07:00June 9, 2026|

City Therapeutics Raises $99.5M in Series B Funding

SWI Editorial Staff2026-06-09T01:31:17-07:00June 9, 2026|

Federal, State Tax Laws Boost Data Centers’ Return-on-Investment

SWI Editorial Staff2026-06-09T01:30:05-07:00June 9, 2026|

Stifel reiterates Buy on Seaport Therapeutics stock, $30 target

SWI Editorial Staff2026-06-09T01:21:13-07:00June 9, 2026|

SpaceX IPO: views from the ground

SWI Editorial Staff2026-06-09T01:14:43-07:00June 9, 2026|

Will the Stock Market Crash if the Federal Reserve Raises Interest Rates? Soaring Bond Yie

SWI Editorial Staff2026-06-09T01:12:00-07:00June 9, 2026|